Inicio › Enfermedad de obstrucción pulmonar crónica › Kansas
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Kansas
12 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Kansas.
Ciudades en Kansas
Texto oficial del estudio (inglés)
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Kansas Medical Center- Site Number : 8400005, Kansas City
ReclutandoFase 4
Edades de 40 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- University of Kansas Medical Center- Site Number : 8400054, Kansas City
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Kansas Medical Center, Kansas City
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Kansas City
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06878261A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd, Kansas City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Kansas Medical Center, Kansas City
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Wichita
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Cotton O'Neil Clinical Research Center, Topeka
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07684820Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
- University of Kansas Medical Center, Kansas City
ReclutandoEstudio observacional
Edades de 18 a 65 · Todos los sexos · Actualizado el 1 jul 2026 · NCT06985225Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 3 en adelante · Todos los sexos · Actualizado el 6 may 2026 · NCT04624490Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Kansas Medical Center Research Institute, Kansas City
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 24 abr 2026 · NCT06891755Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Aton Health, Leawood
- Ascension Via Christi Wichita, Wichita
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.